AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
211.96
-6.08 (-2.79%)
At close: Nov 3, 2025, 4:00 PM EST
212.22
+0.26 (0.12%)
After-hours: Nov 3, 2025, 7:08 PM EST
AbbVie Stock Forecast
Stock Price Forecast
The 18 analysts that cover AbbVie stock have a consensus rating of "Buy" and an average price target of $233.89, which forecasts a 10.35% increase in the stock price over the next year. The lowest target is $190 and the highest is $284.
Price Target: $233.89 (+10.35%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 5 | 6 | 5 | 4 |
| Buy | 11 | 11 | 12 | 12 | 12 | 11 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 22 | 23 | 22 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $240 → $235 | Hold | Maintains | $240 → $235 | +10.87% | Nov 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $250 → $260 | Buy | Maintains | $250 → $260 | +22.66% | Nov 3, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $227 → $242 | Strong Buy | Maintains | $227 → $242 | +14.17% | Oct 20, 2025 |
| Raymond James | Raymond James | Buy Reiterates $236 → $250 | Buy | Reiterates | $236 → $250 | +17.95% | Oct 17, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $231 → $284 | Buy | Maintains | $231 → $284 | +33.99% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
61.97B
from 56.33B
Increased by 10.00%
Revenue Next Year
67.65B
from 61.97B
Increased by 9.17%
EPS This Year
10.76
from 2.39
Increased by 350.15%
EPS Next Year
14.51
from 10.76
Increased by 34.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.3B | 72.1B | |||
| Avg | 62.0B | 67.7B | |||
| Low | 59.1B | 63.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.1% | 16.4% | |||
| Avg | 10.0% | 9.2% | |||
| Low | 4.9% | 2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.37 | 16.35 | |||
| Avg | 10.76 | 14.51 | |||
| Low | 10.19 | 12.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 375.8% | 52.0% | |||
| Avg | 350.2% | 34.9% | |||
| Low | 326.4% | 18.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.